Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shi Du Yan

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of Alzheimer'S Disease : JAD|April 24, 2009
RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?Shi Du Yan, Angelika Bierhaus, Peter P Nawroth, et al.
Ageing Research Reviews|June 1, 2002
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetesDavid M Stern, Shi Du Yan, Shi Fang Yan, et al.
Endocrinology and Metabolism Clinics of North America|September 9, 2006
Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEingShi Fang Yan, Shi Du Yan, Kevan Herold, et al.
Neurobiology of Aging|August 28, 2012
Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid βGayle H Doherty, Dayne Beccano-Kelly, Shi Du Yan, et al.
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGENicola Origlia, Simona Capsoni, Antonino Cattaneo, et al.
Current Diabetes Reports|April 12, 2007
The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complicationsShi Fang Yan, Gaetano R Barile, Vivette D'Agati, et al.
Current Molecular Medicine|March 12, 2008
RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's diseaseXi Chen, Douglas G Walker, Ann Marie Schmidt, et al.
Current Alzheimer Research|June 30, 2012
Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?Eva Borger, Laura Aitken, Heng Du, et al.
Glycobiology|March 15, 2005
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammationRavichandran Ramasamy, Susan J Vannucci, Shirley Shi Du Yan, et al.
Current Atherosclerosis Reports|April 28, 2006
The ligand/RAGE axis: lighting the fuse and igniting vascular stressShi Fang Yan, Yoshifumi Naka, Barry I Hudson, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of Alzheimer'S Disease : JAD|April 24, 2009
RAGE and Alzheimer's disease: a progression factor for amyloid-beta-induced cellular perturbation?Shi Du Yan, Angelika Bierhaus, Peter P Nawroth, et al.
Ageing Research Reviews|June 1, 2002
Receptor for advanced glycation endproducts (RAGE) and the complications of diabetesDavid M Stern, Shi Du Yan, Shi Fang Yan, et al.
Endocrinology and Metabolism Clinics of North America|September 9, 2006
Receptor for advanced glycation end products and the cardiovascular complications of diabetes and beyond: lessons from AGEingShi Fang Yan, Shi Du Yan, Kevan Herold, et al.
Neurobiology of Aging|August 28, 2012
Leptin prevents hippocampal synaptic disruption and neuronal cell death induced by amyloid βGayle H Doherty, Dayne Beccano-Kelly, Shi Du Yan, et al.
Journal of Alzheimer'S Disease : JAD|February 18, 2009
Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGENicola Origlia, Simona Capsoni, Antonino Cattaneo, et al.
Current Diabetes Reports|April 12, 2007
The biology of RAGE and its ligands: uncovering mechanisms at the heart of diabetes and its complicationsShi Fang Yan, Gaetano R Barile, Vivette D'Agati, et al.
Current Molecular Medicine|March 12, 2008
RAGE: a potential target for Abeta-mediated cellular perturbation in Alzheimer's diseaseXi Chen, Douglas G Walker, Ann Marie Schmidt, et al.
Current Alzheimer Research|June 30, 2012
Is amyloid binding alcohol dehydrogenase a drug target for treating Alzheimer's disease?Eva Borger, Laura Aitken, Heng Du, et al.
Glycobiology|March 15, 2005
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammationRavichandran Ramasamy, Susan J Vannucci, Shirley Shi Du Yan, et al.
Current Atherosclerosis Reports|April 28, 2006
The ligand/RAGE axis: lighting the fuse and igniting vascular stressShi Fang Yan, Yoshifumi Naka, Barry I Hudson, et al.
Pageof 5